Our Pipeline

The Spinoff Prize_One to watch 2020_2_Wh
Our pipeline assets range from a cell therapy targeting the root cause of many autoimmune diseases, to a  monoclonal antibody for a new immuno-oncology target, and to a clinical diagnostic assay.
Pipeline new latest.png